Question 1

Who are the top researchers at Serpin Pharma (United States)?

Accepted Answer

Ranked on the quality score, Cohava Gelber lead among researchers whose main affiliation is Serpin Pharma (United States).

Question 2

What are the most cited papers from Serpin Pharma (United States)?

Accepted Answer

The most cited paper from Serpin Pharma (United States) is "The Role of IKKβ in Venezuelan Equine Encephalitis Virus Infection" (Moushimi Amaya, Kelsey Voss, Gavin C. Sampey et al., 2014), with 47 citations. Next come "Low-Density Lipoprotein Receptor–Related Protein-1 Is a Therapeutic Target in Acute Myocardial Infarction" (45) and "Cannabinoids Reduce Extracellular Vesicle Release from HIV-1 Infected Myeloid Cells and Inhibit Viral Transcription" (27).

Question 3

Which research topics does Serpin Pharma (United States) publish most on?

Accepted Answer

By volume in 2022-now: HIV Research and Treatment, HIV-related health complications and treatments, Immune cells in cancer and Atherosclerosis and Cardiovascular Diseases.

Question 4

Which fields of science does Serpin Pharma (United States) work in?

Accepted Answer

In all years, 63% of research at Serpin Pharma (United States) is in Health Sciences, 37% in Life Sciences. Its largest fields are Medicine (63%), Biochemistry, Genetics and Molecular Biology (17%), Immunology and Microbiology (14%). It does 1.4× the world's share of Health Sciences.

Question 5

Is Serpin Pharma (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 67% higher than in 2018-2021.